Lapatinib Withdrawn Phase 1 Trials for Cancer, Breast

IndicationsStatusPurposePhase
WithdrawnNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00898573Lapatinib Resistance in Patients With Breast Cancer